Adil El Housseini

Adil El Housseini

Auto-generated profile, based on publicly available information

Adil El Housseini

AQUAMAR Laboratory, Faculty of Sciences, Ibn Zohr University, Morocco

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in Toxicon
Verified
Journal Article
Closed access
AHAdil EL Housseini
Adil EL Housseini
AAAbdelmohcine Aimrane
Abdelmohcine Aimrane
YJYoussef EL Joud
Youssef EL Joud
MLMehdi Ait Laaradia
Mehdi Ait Laaradia
ELEl-Mustapha Laghzaoui
El-Mustapha Laghzaoui
EAEt Mustapha Agnaou
Et Mustapha Agnaou

26 September 2025
Verified
Book Chapter
Closed access
SMSaloua Mabsor-Zgandaoui
Saloua Mabsor-Zgandaoui
KRKhawla Rachmoune
Khawla Rachmoune
IAIlham Aftais
Ilham Aftais
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
IAImade Amradi
Imade Amradi
AMAbdelhalim Mesfioui
Abdelhalim Mesfioui
Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.

7 November 2025
Verified
Book Chapter
Closed access
AHAdil El Housseini
Adil El Housseini
KRKhawla Rachmoune
Khawla Rachmoune
Abdelfatah AitbabaAbdelfatah Aitbaba
Abdelfatah Aitbaba
YHYoussef Ait Hamdan
Youssef Ait Hamdan
IAImade Armadi
Imade Armadi
MAMustapha Agnaou
Mustapha Agnaou
Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.

26 September 2025
Verified
Book Chapter
Closed access
KRKhawla Rachmoune
Khawla Rachmoune
SMSaloua Mabsor-Zgandaoui
Saloua Mabsor-Zgandaoui
AHAdil El Housseini
Adil El Housseini
YHYoussef Ait Hamdan
Youssef Ait Hamdan
MBMaryam Bousaid
Maryam Bousaid
AMAdnane Moutaouakkil
Adnane Moutaouakkil
Ionizing radiation (IR) plays a central role in the biomedical field, both for diagnosis and for the treatment of pathologies such as cancer. However, exposure to IR can cause significant cellular damage, affecting both tumor cells and neighbouring healthy tissue. In this context, the use of effective radioprotective agents is a necessity. Chitosan (CS), a natural biopolymer derived from chitin, stands out for its antioxidant, anti-inflammatory and reparative properties, as well as its biocompatibility and biodegradability. These characteristics make it a promising candidate for radiation protection. This chapter examines the radioprotective mechanisms of chitosan, in particular its ability to trap reactive oxygen species and enhance the activity of antioxidant enzymes. It also highlights its many biomedical applications, particularly in tissue engineering and controlled drug release. Finally, the limits to its clinical use and recent advances aimed at improving its physico-chemical properties are discussed, paving the way for new therapeutic strategies in radiation protection.

26 September 2025
Verified
Book Chapter
Closed access
YHYoussef Ait Hamdan
Youssef Ait Hamdan
IAImade Armadi
Imade Armadi
KRKhawla Rachmoune
Khawla Rachmoune
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
MMMaryem Mekouar
Maryem Mekouar
MRMohammed Rhazi
Mohammed Rhazi
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.

10 July 2026
Verified
Book Chapter
Closed access
AHAdil El Housseini
Adil El Housseini
KRKhawla Rachmoune
Khawla Rachmoune
SASara El Aimani
Sara El Aimani
YJYoussef El Joud
Youssef El Joud
MHMoulay Abdelmonaim El Hidan
Moulay Abdelmonaim El Hidan
MAMustapha Agnaou
Mustapha Agnaou
Scorpion venom is known for its richness in bioactive molecules, particularly peptides, which confer a wide range of remarkable biological activities. Notably, it exhibits antimicrobial, antitumor, and immunomodulatory effects. However, its clinical translation remains limited due to its poor stability, dose-dependent toxicity, and potential immunogenicity. In this context, biodegradable biomaterials have emerged as promising platforms to overcome these limitations. They enable precise, targeted, and sustained delivery of scorpion venom peptides. This chapter highlights an innovative approach based on the integration of scorpion venom into biodegradable biopolymer matrices for applications in modern medicine. By leveraging the unique properties of biodegradable biomaterials, this work outlines a roadmap for the development of next-generation clinical applications.